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Introduction
Light is the strongest environmental time cue for resetting the circadian clock in mammals, including 
humans (1, 2). Initial studies examining the phase-resetting effects of  light used long-duration (5 hours) and 
high-intensity (~9,500 lux) light (2) because the human circadian system was thought to be less sensitive to 
light than that of  other mammals. While the circadian pacemaker in mice (3), rats (4), hamsters (5), and 
humans (6, 7) is known to respond to a sequence of  millisecond flashes (administered over 5 seconds in 
rats, over 5–60 minutes in mice and hamsters, and over 60 minutes in humans), a single millisecond flash 
does not reset the mammalian pacemaker at the intensities that have been tested (3, 8), suggesting that cir-
cadian resetting requires integration of  the photic signal over a longer exposure interval.
A nonlinear relationship exists between light exposure (LE) duration and the magnitude of  circadian 
phase resetting responses. A single 12-minute pulse of  light can shift the human pacemaker 8 times more 
BACKGROUND. In humans, a single light exposure of 12 minutes and multiple-millisecond light 
exposures can shift the phase of the circadian pacemaker. We investigated the response of the 
human circadian pacemaker to a single 15-second or 2-minute light pulse administered during the 
biological night.
METHODS. Twenty-six healthy individuals participated in a 9-day inpatient protocol that included 
assessment of dim light melatonin onset time (DLMO time) before and after exposure to a single 
15-second (n = 8) or 2-minute (n = 12) pulse of bright light (9,500 lux; 4,100 K fluorescent) or control 
background dim light (<3 lux; n = 6). Phase shifts were calculated as the difference in clock time 
between the two phase estimates.
RESULTS. Both 15-second and 2-minute exposures induced phase delay shifts [median (± SD)] 
of –34.8 ± 47.2 minutes and –45.4 ± 28.4 minutes, respectively, that were significantly (P = 0.04) 
greater than the control condition (advance shift: +22.3 ± 51.3 minutes) but were not significantly 
different from each other. Comparisons with historic data collected under the same conditions 
confirmed a nonlinear relationship between exposure duration and the magnitude of phase shift.
CONCLUSIONS. Our results underscore the exquisite sensitivity of the human pacemaker to even 
short-duration single exposures to light. These findings may have real-world implications for 
circadian disruption induced by exposure to brief light stimuli at night.
TRIAL REGISTRATION. The study was registered as a clinical trial on www.clinicaltrials.org,  
NCT #01330992.
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efficiently per minute of  exposure than a 240-minute (i.e., 4-hour) pulse (9). Intermittent LEs (e.g., 15 min-
utes every 75 minutes) over the same total 6.5-hour duration induce an ~2.5-hour phase delay, which is 
~75% of  the phase-resetting effect of  6.5 hours of  continuous light, despite representing only 23% of  the 
total light duration, suggesting integration of  the photic signal over the exposure interval (10, 11).
The goal of  the current study was to test the hypothesis that single discrete brief  light stimuli, short-
er than 12 minutes, will induce greater circadian phase shifts than dim ambient lighting. Moreover, we 
hypothesized that most of  the resetting response will be induced by the early part of  the LE, consistent 
with a nonlinear relationship between light duration and phase resetting response (12). Therefore, in the 
current study, we investigated the magnitude of  phase resetting responses in humans exposed to very brief  
LEs (either 15 seconds or 2 minutes of  bright [~9,500 lux] light) administered during the biological night as 
compared with a dim light (<3 lux) control condition. These phase-resetting responses were compared with 
historic data (9) that examined light pulses of  12 minutes, 1 hour, 2.5 hours, and 4 hours collected under 
the same experimental conditions.
Results
LE-induced phase shifts. To examine the effects of  different short-duration pulses of  bright light on circadian 
phase resetting, we studied 26 healthy individuals (Figure 1) in a 9-day inpatient protocol (Figure 2A) that 
included assessment of  endogenous circadian phase before and after they were exposed to a single 15- 
second (n = 8) or 2-minute (n = 12) pulse of  bright light (9,500 lux; 4,100 K fluorescent) or to control back-
ground dim light (<3 lux; n = 6). LE-induced phase shifts were calculated as the difference in circadian 
phase assessed before and after LE using constant routine protocols in a 9-day inpatient study (Figure 2, A 
and B). Circadian phase was assessed as the time at which melatonin secretion began under dim light (i.e., 
dim light melatonin onset [DLMO]). The DLMO for each individual for each study day under each of  the 
three conditions are shown in Figure 3, A–C; phase shifts are shown for each individual under each con-
dition in Figure 3, D–F. Both the 15-second and 2-minute exposures induced median phase shifts (–34.81 
Figure 1. CONSORT diagram for this phase I nonrandomized trial showing enrollment, allocation, and analysis. Sixty-seven participants were assessed 
for eligibility; 26 completed the protocol, and 22 were included in the final analysis.
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± 47.19 minutes and –45.44 ± 28.36 minutes, respectively) significantly (P = 0.04) different 
from the median phase shift under the dim light control condition (22.31 ± 51.36 minutes) 
(Figure 3G). The responses to the two LEs were not different from each other, however (P 
= 0.98). The 4-parameter logistic function fit to the new and historical data (stimulus dura-
tion ranging from 15 seconds to 4 hours) had a goodness of  fit of  r = 0.69 with estimates (± 
SE) for a (maximum asymptote) = –3.07 ± 2.81 hours, b = 1.76 ± 5.62 hours, c (minimum 
asymptote) = –48.70 ± 16.01 minutes, and d (ratio of  minutes of  phase shift per minute of  
bright LE) = –48.73 ± 58.01. This fit estimates the half-maximal phase shift (parameter b) at 
a light duration of  1.76 hours, at this light intensity (Figure 3H).
The 15-second and 2-minute exposures induced phase delays that represent ~26% and 
~34% of  the resetting observed with a 4-hour exposure, despite representing only 0.10% and 
0.83%, respectively, of  the 4-hour stimulus duration. Thus, compared with the 4-hour pulse, 
which gave 0.01 minutes phase delay per second of  LE, the 15 second pulse was ~230 times 
more effective (2.32 minutes delay per second of  exposure), and the 2 minute pulse was ~38 
times more effective (0.38 minutes delay per second of  exposure).
Discussion
Our results show that single bright LEs as short as 15 seconds and 2 minutes induce significant circadian 
phase shifts in humans. These results also confirm and further refine the nonlinear duration response func-
tion to light previously reported (9). To our knowledge, this is the first study to demonstrate a significant 
phase-resetting response to a single short-duration (15 seconds) light pulse.
The nonlinear relationship between exposure duration and the degree of  circadian phase shift has been 
modeled previously using a 4-parameter logistic function and showed an approximately linear response 
between 12 minutes and 4 hours (9). Our new results confirm a nonlinear logistic relationship when shorter 
pulses are added to the function. Our fit estimated the half-maximal phase shift at ~1.76 hours LE duration, 
at this light intensity, markedly shorter than the previously reported regression estimate of  ~2.7 hours (9).
The higher-than-expected phase resetting capacity of  the short-duration pulses (≤ 12 min) suggests that 
most of  the phase resetting in a long--duration pulse likely occurs at the onset of  the LE. This supports 
the Kronauer model (12) of  the effects of  LE on phase resetting in humans, which predicts that there is a 
greater activation rate of  light-sensitive elements (a measure of  resetting effectiveness of  light) at the very 
beginning of  a light pulse, defined as the “prompt response” (12). In this model, as activator elements are 
depleted into a “used” state, the light drive to the pacemaker becomes limited by the rate at which elements 
are recycled back to a “ready” state, and it is maintained asymptotically marginally above baseline non-
activated levels, defined as the sustained drive (12). The rate of  decline from the prompt to the sustained 
drive follows a nonlinear pattern. Our results in humans are consistent with results from animal studies 
that showed light-induced phase resetting to be most efficient at the beginning of  the LE, with minimal 
additional phase shift produced by further extension of  the light stimulus due to a reduction in photic 
responsiveness of  the circadian pacemaker (3, 4, 8, 13). A recent report documents that the number of  
light-evoked action potentials per photon from intrinsically photosensitive retinal ganglion cells (ipRGCs) 
that mediate LE-induced phase shifts declines as the duration of  the photic stimulus increases (14). This 
is likely related to the light adaptation of  ipRGCs with sustained photic stimulation (15). These results 
Figure 2. Study protocol and phase shift calculation. All study events were timed according to each 
individual’s schedule, which was maintained for at least three weeks prior to starting the 9-day 
inpatient part of the study. (A) Example study raster for an individual with 2300–0700 hours habitual 
sleep. Black bars represent scheduled sleep (time in bed) in darkness, and white bars represent <200 
lux ambient lighting while awake. Gray bars represent dim light (<3 lux). Gray hashed bars represent 
constant routine intervals used to assess endogenous circadian phase. The constant posture interval 
during light exposure is shown as gray dotted bars, and the time of bright light exposure (9,500 lux) 
is represented by a hashed white bar. Daily dim light melatonin onset (DLMO) times from 1 individ-
ual in the control condition is plotted across the days (●, under dim light; ○, melatonin crossing the 
DLMO value under 90 lux room light). (B) Daily melatonin profiles from the same individual plotted 
serially. The dashed square represents the constant posture interval during which light exposure 
occurred. All individuals in the control condition received the same dim background ambient lighting 
and no bright light exposure. Black horizontal lines above the melatonin profiles indicate scheduled 
sleep. Phase shifts were assessed as the difference in clock time between DLMO on cycles d and g.
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provide a cellular explanation for the change in phase resetting efficiency 
based on the duration of  the light pulse as observed in the current study.
Exposure to multiple short pulses (5, 15, and 45 minutes) delivered 
over a long-exposure interval (e.g., 6.5 hours) has been shown to induce 
significant phase shifts in humans (10, 11, 16). More recently, a train 
of  sixty 2-millisecond pulses administered every minute over 60 min-
utes induced ~45 minutes of  phase delay (6, 7). Given that the circadian 
pacemaker can integrate photic signals (3, 8), these multiple-exposure 
studies cannot isolate the phase shift induced by each individual pulse. 
Mechanistic studies of  phase resetting in animals show that the pace-
maker can integrate and respond to pulses presented 60 minutes apart 
(17) and that the majority of  a phase-resetting response occurs at the 
beginning of  the light pulse (18–20). Our current results suggest that 
humans may also be disproportionately sensitive to the first few seconds 
of  a light stimulus (12).
This study had a number of  limitations. Firstly, the limited sam-
ple size in each LE condition may have precluded detecting differ-
ences in phase shifts between the 15-second and 2-minute exposures. 
Secondly, the magnitude of  the shifts in the short-duration pulses is 
close to the limit of  detection for our study techniques. In the current 
analyses, we assessed phase shifts over three cycles, consistent with 
previous studies (21–23); however, the endogenous drift over multiple 
circadian cycles between assessments may influence the phase shift 
results compared with results calculated across only one or two cir-
cadian cycles (22, 24, 25). Additionally, the studies were performed 
against a dim light background, which reduces the masking effects 
of  light on the circadian pacemaker but can cause moderate sensiti-
zation of  the system to subsequent bright LEs (26, 27). Although the 
mean illuminances appeared to differ between the duration condi-
tions with up to a ~45% difference between the highest mean (9,040 
lux, 1 hour condition) and lowest mean intensities (6,226 lux, 2 minute condition), it is highly unlikely 
that this affected the phase resetting responses. Even the lowest mean intensity was more than 10 
times higher than the ~500 lux intensity at which phase resetting responses saturate in studied under 
conditions that are similar to the current study (28). Moreover, the 1-hour condition had lower phase 
resetting efficiency than the 15-second and 2-minute conditions, even though the mean intensity of  the 
1-hour condition was higher than the other two conditions.
Figure 3. Phase resetting response to short-duration pulses of light and dura-
tion response of circadian phase resetting. Daily dim light melatonin onset 
(DLMOs) times for each individual are shown for (A) dim-light control and (B) 
15-second and (C) 2-minute exposure conditions. Light exposure occurred on 
day 6 (gray arrow, dim light; black arrow, bright light). (D–F) Individual mela-
tonin profiles across ~24 hours during the (●) first constant routine (CR1) and 
(○) second CR (CR2) under each of the three light exposure conditions demon-
strate the phase resetting effects of bright-light exposure compared with dim 
light. (G) Phase shifts of the human circadian system in response to dim-light 
control (n = 9) and to 15-second (n = 7) and 2-minute (n = 10) high-intensity 
night-time light (~9,500 lux) exposure. The box and whisker plots show the 
median, 25th and 75th percentile (box limits), the 10th and 90th percentiles 
(whiskers), and the maximum and minimum points, which are represented as 
filled circles. *P < 0.05 by Kruskal-Wallis one-way ANOVA followed by post hoc 
multiple comparisons using Wilcoxon rank-sum test. All tests were 2-tailed. 
(H) Phase resetting response (median ± SD) to 15-second (n = 7), 2-minute 
(n = 10), 12-minute (n = 8), 1-hour (n = 7), 2.5-hour (n = 9), and 4-hour (n = 8) 
night-time light (~9,500 lux) pulses fitted with a 4-parameter logistic model. 
Individual phase shifts are shown as ○. The 95% CI region of the regression is 
shown as the shaded area.
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These results have important physiological and clinical implications. Light levels equivalent to ordi-
nary room light (~100 lux) induce half-maximal phase shifts compared with bright light (~1,000–10,000 
lux) when the stimuli are 6.5 hours long (28). Results from the current study demonstrate that even 
short-duration exposures (on the order of  seconds) can cause significant phase resetting. Taken together, 
the results warrant future studies to examine the effects of  short-duration LEs at indoor intensities on cir-
cadian phase resetting. Such inadvertent phase resetting may be an unrecognized risk factor for insomnia, 
circadian rhythm sleep disorders, and a variety of  adverse health effects associated with circadian rhythm 
disruption. Alternatively, the effectiveness of  these short-light stimuli for resetting circadian rhythms may 
have potential therapeutic value to improve compliance with treatments for circadian misalignment asso-
ciated with shift-work, jet-lag, and other circadian rhythm sleep disorders.
Methods
Participants and prestudy conditions
Twenty-six young healthy individuals (15 females; mean age ± SD = 23.6 ± 3.3 years; range 19–30 years) 
completed the protocol (Figure 1) in the Intensive Physiological Monitoring Unit in the Center for Clinical 
Investigation (CCI) at Brigham and Women’s Hospital. The study included three groups: 15-second (n = 
8; 5 female; mean age [±SD], 24.2 ± 4.3 years) or 2-minute (n = 12; 6 female; mean age [±SD], 23.3 ± 3.0 
years) LE conditions, and the dim-light control condition (n = 6; 4F; mean age [±SD] 23.8 ± 2.7 years). 
Data from six individuals who voluntarily withdrew prior to study completion were not included in the 
analyses. All were healthy by physical, psychological, and ophthalmologic exams. For at least three weeks 
prior to admission, participants maintained a self-selected, consistent 8-hour sleep/rest/dark schedule that 
was confirmed with calls to a time- and date-stamped voicemail at bedtime and wake time and, for at least 
7 days prior to entering the unit, objective monitoring with actigraphy and photometry (Actiwatch-L, Min-
imitter Inc.). Throughout screening, participants were asked to refrain from the use of  any prescription or 
nonprescription medications, supplements, recreational drugs, caffeine, alcohol, or nicotine. Compliance 
was verified by urine and blood toxicology during screening and urine toxicology upon entry to the unit.
Study protocol
Participants were studied for 9 days in an environment free of  time cues and were supervised by staff  
trained not to reveal information about the time of  day. The schedule consisted of  a 3-day baseline (8 
hours/16 hours sleep/wake cycle based on average sleep times in the 7 days prior to study entry), an initial 
50-hour constant routine circadian phase assessment (CR1, described below), and a 16-hour wake episode 
during which the experimental LE was presented (LE day). This was followed by an 8-hour scheduled sleep 
opportunity, a 30-hour CR (CR2), and then a final 8-hour sleep opportunity, after which time they were 
discharged (Figure 2A). During the CR procedures (29), participants were asked to remain awake while 
supervised in constant dim light in a semirecumbent posture, with daily nutritional and fluid intake divided 
into isocaloric hourly portions.
Lighting conditions and experimental LE
Ambient light conditions. During the first 2.5 baseline days, maximum ambient light during scheduled wake 
was ~190 lux (~48 μW/cm2) when measured in the horizontal plane at a height of  187 cm and ~88 lux 
(~23 μW/cm2) when measured in the vertical plane at a height of  137 cm. Midway through day 3, ambi-
ent light was decreased to <3 lux maximum (1.5 lux [<0.4 μW/cm2 to ~0.1 μW/cm2]) when measured in 
the vertical plane at 137 cm and maintained at that level for the remainder of  the study, except during the 
brief  experimental LEs (see below) and during scheduled sleep opportunities when all lights were turned 
off  (0 lux). The ambient lights were dimmed midway through day 3 in order to assess DLMO time as a 
phase estimate under entrained conditions (9, 30).
Experimental LE conditions. The LE procedure included a constant posture episode during which the 
bright light pulse was administered. The constant posture was used to negate confounding from ambula-
tory conditions on research measurements (9). The constant posture began 5.7 hours after wake time on 
the LE day and lasted for 4.5 hours (to accommodate the longest exposure of  4 hours) (9). The 4.5-hour 
constant posture interval was approximately centered within the 16-hour wake episode, therefore starting 
5.7 hours after wake and ending 5.8 hours before bedtime on that study day. The LE was centered on the 
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16-hour wake episode, which occurred 7.9 hours after wake (2.2 hours after the start of  the constant pos-
ture) for the 15-second and 2-minute pulses, respectively.
During the constant posture, participants remained seated in a specific location of  the room and wore 
clear UVEX glasses (Uvex Winter Optical) to remove UV radiation. During the constant posture interval, 
when participants remained in dim background light, participants alternated fixed gaze (lasting at least 5 
minutes) with an equal interval of  “free gaze.” During fixed gaze, participants focused on a target on the 
wall directly in front of  them and during free gaze, participants were allowed to look elsewhere as long as 
they did not close their eyes or shield them from the light. Light illuminance was measured at every change 
of  gaze, with the sensor placed next to the participant’s eye and pointed at the target during fixed gaze 
and in the angle of  gaze during free gaze. Starting 10 minutes immediately prior to the light pulse, all par-
ticipants maintained fixed gaze. During bright light pulses > 2 minutes, participants continued with their 
fixed and free gaze pattern, whereas during light pulses ≤ 2 minutes, participants stared directly above at 
the ceiling where the lights were located for the duration of  the bright light pulse. In the control condition, 
the same sequence as in the 2-minute exposure was followed. During the 15-second or 2-minute LE within 
this session, the target corneal illuminance was >9,500 lux (>8 × 106 μW/cm2); for the control condition, 
background lighting (<3 lux) was maintained. The mean ± SD illuminance achieved during the 15-second 
pulse was 8,022 ± 1,387 lux; during the 2-minute pulse, it was 6,226 ± 1,546 lux; and during the control 
condition, it was 0.5 ± 0.2 lux. A research technician was present during the entire LE session to administer 
the LE, measure and record light readings, and monitor adherence to study procedures.
Technical details of  light generation and measurement. Ambient room lighting was generated using ceil-
ing-mounted 4,100 K fluorescent lamps (F96T12/41U/HO/EW, 95W; F32T8/ADV841/A, 32W; F25T8/
TL841, 25W; Philips Lighting) with digital ballasts (Hi-Lume 1% and Eco-10 ballasts, Lutron Electronics 
Co. Inc.) transmitted through a UV-stable filter (Lexan 9030 with prismatic lens, GE Plastics). Routine 
illuminance and irradiance measures were conducted using an IL1400 radiometer/powermeter with an 
SEL-033/Y/W or SEL-033/F/W detector, respectively (International Light Inc.).
Outcome measures of melatonin phase
Blood samples were collected every 5–60 minutes throughout the protocol, and the plasma was fro-
zen for later assay. Melatonin concentration was determined by double-antibody radioimmunoassay 
with the Kennaway G280 antiserum (31) by a laboratory blinded to experimental conditions (Specialty 
Assay Research Core Laboratory, Brigham and Women’s Hospital). The plasma melatonin intra-assay 
coefficient of  variation (%CV) was 8.5% at 5.85 pg/ml and 8.0% at 25.46 pg/ml, and the interassay 
%CV was 10.8% at 5.98 pg/ml and 14.5% at 23.07 pg/ml.
The DLMO was used as the endogenous circadian phase marker and calculated as the time at which lev-
els of  melatonin rose above the 25% peak-to-trough amplitude threshold of  a 3-harmonic waveform fitted to 
the first melatonin secretory episode during CR1 (30, 32). Once the threshold for each individual’s DLMO 
was calculated, it was applied to each daily melatonin onset and described by letter (a–g; see Figure 2B).
Historic data
In addition to those participants described above, (i) four male participants (21.0 ± 1.8 years) previously 
studied in our laboratory using a near-identical protocol under dim light conditions were included in the 
control condition for the phase shift analysis (22), and (ii) 39 healthy young adults (22.2 ± 3.6 years; 16 
female) previously studied in our laboratory using near-identical procedures in a protocol that examined 
the phase shifts in response to LEs of  12 minutes, 1 hour, 2.5 hours, and 4 hours were reanalyzed to eval-
uate a broader duration response of  circadian phase resetting (9). The current and historical studies were 
the same in participant screening criteria and experimental conditions, except for the (i) LE duration and 
timing and (ii) CR duration. The 4-hour LE was scheduled to begin 0.5 hours after the start of  the 4.5-hour 
constant posture session (6.2 hours after wake time) and end at the same time as the LE session in this 
protocol. The 2.5-hour and 1-hour LEs were each scheduled so that the midpoint of  the LE occurred at the 
same time of  the midpoint for the 4-hour LE (8.2 hours after wake time). The timing of  the 12-minute LE 
occurred slightly earlier, with the midpoint 12 minutes earlier than the other groups. CR1 was a 50-hour 
wake episode (same as the current study) in the 12-minute condition and a 50.2-hour wake episode in the 
1-hour, 2.5-hour, and 4-hour conditions. CR2 was a 30-hour wake episode (same as the current study) in 
the 12-minute condition and a 29.8-hour wake episode in the 1-hour, 2.5-hour, and 4-hour conditions (9). 
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The mean (± SD) light intensities for the historic conditions were as follows: 12 minutes was 7,669 ± 1,321 
lux, 1 hour was 9,040 ± 498 lux, 2.5 hours was 8,927 ± 666 lux, and 4 hours was 8,396 ± 1,604 lux (9).
Data analysis
Data are reported as the median (±SD) unless otherwise noted. All analyses were performed using SAS 
9.3 (SAS Institute Inc.). Data from 22 of  the 26 current participants were included in the analysis of  
melatonin phase shifts. One male participant from the control condition was excluded due to significant 
daytime melatonin secretion such that a reliable DLMO could not be determined. For two participants 
(n = 1 from each of  the two LE groups; both females), post-hoc analysis revealed that the LE was 4.4 
hours after DLMO, which was outside the target range (0.1–4.1 hours) for inducing 85% of  the maximal 
delay shift (22), so they were excluded from analysis. DLMO in the second cycle of  CR2 could not be 
assessed in 1 female participant in the 2-minute exposure group due to missing blood samples result-
ing from i.v. malfunction. Four participants (n = 3 from the 1-hour group and n = 1 from the 2.5-hour 
group) from the historical cohort were also excluded from the analysis due to inappropriate timing of  
the LE as per the target range described above.
Phase shifts were calculated as the difference between the DLMO on the second cycle of  CR1 (pre-LE 
phase) and the DLMO on the second cycle of  CR2 (post-LE phase) three cycles later (cycles d and g; Figure 
2A and B) (21–23). Median melatonin phase shift data for each LE duration group were fit by a 4-param-
eter logistic model to characterize the relationship between phase shift and light duration (SAS PROC 
NLMIXED). The 4-parameter logistic model was previously found to best fit the relationship between 
phase shift and stimulus duration or intensity (9, 28). The equation for the 4-parameter logistic model was 
as follows: y = ([a – c] / [1 + (x/b)d]) + c, where “a” is the estimated response of  the system to a bright 
light pulse of  0-second duration, “b” is the duration at which 50% of  the maximal shift is observed, “c” is 
the asymptotic maximal responsiveness of  the system, and “d” is a measure of  the steepness of  the rising 
portion of  the curve. 
Statistics
All statistical analyses were performed using SAS 9.3 (SAS Institute Inc.). Due to the limited sample sizes in 
each group, phase shift data were analyzed by the nonparametric Kruskal-Wallis one-way ANOVA to assess 
the differences in median phase shifts between LE conditions. Post hoc multiple comparisons were made 
using Wilcoxon rank-sum test. All statistical tests were two-tailed with a significance threshold set to P < 0.05. 
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